SCHEMBL25910968

SCHEMBL25910968

CC(=O)c1ccc2[nH]c(-c3ccc(O)cc3)cc(=O)c2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.55
▸ RAB9A P51151 7/20 0.55
▸ HPGD P15428 7/20 0.55
▸ NPC1 O15118 6/20 0.55
▸ SMN1; SMN2 Q16637 6/20 0.55
▸ ALDH1A1 P00352 5/20 0.55
▸ MEN1 O00255 3/20 0.55
▸ KMT2A Q03164 3/20 0.55
▸ LMNA P02545 3/20 0.55
▸ MAPK1 P28482 1/20 0.55
▸ TUBB4A P04350 1/20 0.54
▸ TUBB P07437 1/20 0.54
▸ TUBA3C P0DPH7 1/20 0.54
▸ TUBA1B P68363 1/20 0.54
▸ TUBA4A P68366 1/20 0.54
▸ TUBB4B P68371 1/20 0.54
▸ TUBB3 Q13509 1/20 0.54
▸ TUBB2A Q13885 1/20 0.54
▸ TUBB8 Q3ZCM7 1/20 0.54
▸ TUBA3E Q6PEY2 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25910928 0.88 HPGD (0.54) KDM4ERAB9AHPGDNPC1SMN1; SMN2
SCHEMBL25910932 0.88 SMN1; SMN2 (0.63) KDM4ERAB9AHPGDNPC1SMN1; SMN2
SCHEMBL25911115 0.87 TUBB4A (0.69) KDM4ERAB9AHPGDNPC1SMN1; SMN2
SCHEMBL25910967 0.85 TUBB4A (0.54) KDM4ERAB9AHPGDNPC1SMN1; SMN2
SCHEMBL25910937 0.85 ALDH1A1 (0.73) KDM4ERAB9AHPGDNPC1SMN1; SMN2
SCHEMBL312000 0.84 HPGD (0.61) KDM4ERAB9AHPGDNPC1SMN1; SMN2
SCHEMBL29902940 0.82 TUBB4A (0.80) KDM4ERAB9AHPGDNPC1SMN1; SMN2
SCHEMBL22552099 0.82 TUBB4A (0.80) KDM4ERAB9AHPGDNPC1SMN1; SMN2
SCHEMBL15223801 0.81 HDAC6 (0.53) HSD17B1
SCHEMBL25911109 0.80 MAPT (0.60) KDM4ERAB9AHPGDNPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230233549-A1 METHODS OF USING 4(1H)-QUINOLONE DERIVATIVES ACADEMIA SINICA (TW) 2023-07-27 — — US disclosed
US-11638705-B2 4(1H)-quinolone derivatives and uses thereof ACADEMIA SINICA (TW) 2023-05-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11638705-B2 4(1H)-quinolone derivatives and uses thereof TUBB1, TUBB3, TUBB KDM4E 4231/4885RAB9A 1780/4885HPGD 794/4885
US-20230233549-A1 METHODS OF USING 4(1H)-QUINOLONE DERIVATIVES TUBB1, TUBB3, TUBB KDM4E 4301/4885RAB9A 1690/4885HPGD 1023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback